Plasma GPC3 reflects tumor GPC3 expression and predicts clinical outcomes in advanced HCC treated with atezolizumab + bevacizumab

ABSTRACT:

SUBMITTER: Shin D 

PROVIDER: S-EPMC12936939 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature